医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Clinigen signs agreement with Nordic Pharma for aprotinin

2018年05月24日 PM05:00
このエントリーをはてなブックマークに追加


 

BURTON-ON-TRENT, England

Clinigen Group plc (AIM: CLIN, ‘Clinigen’), the global pharmaceutical and services company, has signed an agreement with Nordic Pharma Ltd. (‘Nordic Pharma’) to manage the supply and distribution of aprotinin in a range of countries in Asia Pacific and South Africa.

Aprotinin Injection belongs to a group of medicines called anti-fibrinolytics (medicines to prevent blood loss). Aprotinin can help to reduce blood loss and the need for blood transfusions during isolated cardiopulmonary bypass graft surgery.

Under the terms of this agreement, Clinigen will make aprotinin available to physicians and pharmacists on an unlicensed, on-demand basis for patients who lack other suitable therapeutic options in a number of countries. The contract grants Clinigen the exclusive rights to supply aprotinin in Australia, New Zealand, Japan, Singapore, Malaysia, Taiwan, Thailand, Hong Kong and South Africa.

Julie Gosper, Head of Global Access, Clinigen, said:

“This agreement demonstrates Clinigen’s ongoing commitment to providing physicians and pharmacists with the access to medicines they require to address patients’ unmet medical needs. We look forward to working with the Nordic Pharma team to enable broader access to this important product.”

Hans Schram, CEO, Nordic Pharma, said:

“Nordic Pharma is committed to improving the access to aprotinin worldwide, which is an important lifesaving product in the arsenal of patient blood management. This collaboration with Clinigen will improve access to this medicine in a number of territories where it is currently not commercially available.”

Healthcare professionals can obtain details about aprotinin by emailing medicineaccess@clinigengroup.com

– Ends –

For the full release, please visit https://www.clinigengroup.com/company/newsroom/press-releases/

View source version on businesswire.com: https://www.businesswire.com/news/home/20180524005061/en/

CONTACT

Clinigen Group plc
Shaun Chilton, Group Chief Executive
Officer
Julie Gosper, Head of Global Access
Tel: +44 (0) 1283
495010
or
Instinctif Partners
Melanie Toyne-Sewell
/ Alex Shaw
Tel: +44 (0) 20 7457 2020
Email: clinigen@instinctif.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Exactech Earns Research Award at International Computer-Assisted Surgery Conference for ExactechGPS® Knee Application
  • 火山噴火で家屋の破壊と住民の避難が続く中、ハワイ・コミュニティ財団が支援基金を創設
  • Octapharma宣布Nuwiq®产品新增剂量规格在欧洲获准,提高了血友病A患者的给药灵活性
  • PHCホールディングス株式会社:薬剤師の業務効率化を目指した保険薬局用電子薬歴システム「PharnesV-MX」を販売開始
  • LG化学举办“全球创新大赛 (GIC)”“寻找改变世界的创新技术”